Michael Lisjak - Aug 27, 2021 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role
Chief Regulatory Officer
Signature
/s/ Michael Lisjak
Stock symbol
CYTH
Transactions as of
Aug 27, 2021
Transactions value $
$0
Form type
4
Date filed
8/30/2021, 07:04 PM
Next filing
Mar 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTH Stock Option (Right to buy) Award $0 +23.8K $0.00 23.8K Aug 27, 2021 Common Stock 23.8K $7.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a four year period in equal monthly installments.